Report
Rayhan Ahmed

Equity Note on The IBN SINA Pharmaceutical Industry PLC (IBNSINA)

The IBN SINA Pharmaceutical Industry PLC (IBNSINA) is a manufacturer and seller of generic drugs in both domestic and international markets. The company produces over 450 generic drugs in various types of dosage forms including tablets, capsules, ampoules, vials, syrup, solutions, suspensions etc. The company exports its generic drugs to 17 countries, including highly regulated markets like the USA.
Underlying
The Ibn Sina Pharmaceutical Industry Limited

Provider
EBL Securities Ltd.
EBL Securities Ltd.

EBL Securities Ltd. (EBLSL) is one of the fastest growing full-service institutional brokerage companies in Bangladesh. On top of our expertise and achievements, we take pride in our strong commitment towards excellent client services and development of the Bangladesh capital markets.

EBLSL is a fully owned subsidiary of Eastern Bank Limited (EBL), one of the leading private commercial banks of Bangladesh. EBLSL is one of the TOP-10 brokerage companies of Bangladesh.

We have unwavering faith in the potential of Bangladesh. We also believe that an efficient, vibrant and transparent capital market can strongly contribute to the overall development of Bangladesh. Bangladesh is currently at the initial stage of capital market growth, and we are committed to assist the entry of early movers into a growth-oriented, vibrant, nascent emerging market.

EBLSL has developed a disciplined approach towards providing capital market services. The foundation for our business is a strong commitment towards market experience & professionalism, investment knowledge, market intelligence and research services.

Analysts
Rayhan Ahmed

Other Reports on these Companies
Other Reports from EBL Securities Ltd.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch